16-89933512-G-A
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PM5PP2PP3_ModeratePP5_Very_Strong
The ENST00000315491.12(TUBB3):c.211G>A(p.Gly71Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G71A) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000315491.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB3 | NM_006086.4 | c.211G>A | p.Gly71Arg | missense_variant | 3/4 | ENST00000315491.12 | NP_006077.2 | |
TUBB3 | NM_001197181.2 | c.-6G>A | 5_prime_UTR_variant | 3/4 | NP_001184110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB3 | ENST00000315491.12 | c.211G>A | p.Gly71Arg | missense_variant | 3/4 | 1 | NM_006086.4 | ENSP00000320295 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727236
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 11, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26639658, 27535533, 34562182, 33921132, 36494820) - |
TUBB3-related tubulinopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Mar 12, 2024 | The p.Gly71Arg variant in TUBB3 was identified by our study in one individual with congenital fibrosis of the extraocular muscles, facial weakness, and simplified gyral pattern of the sylvian fissures, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Engle lab (https://kirbyneuro.org/EngleLab/). Trio genome analysis showed this variant to be de novo. The p.Gly71Arg variant in TUBB3 has been previously reported in 3 unrelated individuals with congenital fibrosis of the extraocular muscles and malformations of cortical brain development (PMID: 26639658). The number of reported affected individuals with this variant is slightly greater than expected compared to non-affected individuals with this variant. This variant was found to be de novo in these 3 individuals with confirmed paternity and maternity (PMID: 26639658). This variant has also been reported in ClinVar (Variation ID: 219255) and has been interpreted as pathogenic by GeneDx. This variant was absent from large population studies. The number of missense variants reported in TUBB3 in the general population is lower than expected, suggesting there is little benign variation in this gene and slightly increasing the possibility that a missense variant in this gene may not be tolerated. One additional likely pathogenic variant, resulting in a different amino acid change at the same position, p.Gly71Ala, has been reported in association with disease in ClinVar, slightly supporting that a change at this position may not be tolerated (Variation ID: 1338328). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant congenital fibrosis of the extraocular muscles with or without extraocular involvement. ACMG/AMP Criteria applied: PS2_VeryStrong, PS4_Supporting, PM2_Supporting, PM5_supporting, PP2 (Richards 2015). - |
TUBB3-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Feb 02, 2024 | PS2, PS4, PM2, PP2 - |
Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at